Spruce Biosciences (SPRB) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Spruce Biosciences (SPRB) is Neutral.

The composite score behind that read is -0.10, weighing +0.18 of bullish evidence against -0.39 bearish.

Spruce Biosciences last closed at $44.05, -3.27% on the session.

Against the IVW growth benchmark the position is -4.07% over the forecast window.

The read is built from 15 underlying insights — 4 bullish and 11 bearish.

Agreement across those insights is 73%.

16 graded predictions for SPRB so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Spruce Biosciences in the 9th percentile on return on equity, where 100 is best.

Spruce Biosciences is classified under Health Care / Biotechnology, with a market capitalisation of $130.88M.

StockMap tracks Spruce Biosciences as the 271st largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Spruce Biosciences ranks 230th of 381 in the group, against a group median of -0.08.